This book aims to address the major aspects of future drug product development and therapy for
older adults giving practical guidance for the rational product and clinical development and
prescribing of drug products to this ever growing segment of the population. With authors
coming from key aging markets such as Europe the USA China and Japan the book will provide
valuable information for students scientists regulators practitioners and other healthcare
professionals from academia industry and regulatory bodies.
